Results 231 to 240 of about 134,162 (275)

Synthesis of Single‐Crystalline Ni‐Rich Cathodes for Lithium‐Ion Batteries With Superior High‐Voltage Stability by Mo/Nb Dual Doping

ENERGY &ENVIRONMENTAL MATERIALS, Volume 9, Issue 6, November 2026.
A novel synthesis method of single‐crystalline LiNi0.8Co0.15Al0.05O2 (NCA) is introduced, involving the stripping of grain boundaries from polycrystalline NCA (PC‐NCA) during Mo/Nb co‐doping. Mo doping near the grain surface significantly reduces parasitic interface reactions and inhibits the excessive growth of CEI films, while Nb doping within the ...
Guomeng Xie, Ziqin Xu, Delai Qian, Ruiwu Li, Qingsong Hua, Shun Lu, Haitao Fang   +6 more
wiley   +1 more source

Beyond numeric scales: validity of the EQ-5D-5L pain/discomfort dimension in postoperative pain assessment after minimally invasive colorectal cancer surgery. [PDF]

Korean J Pain
Cho S, Yoon SH, Lee HJ, Park JH, Kim MJ, Park JW, Ryoo SB, Jeong SY.   +7 more
europepmc   +1 more source

Case‐Mix Adjustment of Multidimensional Patient‐Reported Outcomes to Assess Hospital Performance

Health Economics, Volume 35, Issue 11, Page 1734-1743, November 2026.
ABSTRACT Multidimensional patient‐reported outcome measures (PROMs) are increasingly used to compare the performance of health care providers. Meaningful comparisons require the data to be adjusted for differences in case‐mix. The common approach in the literature is to aggregate PROM data into univariate summary scores prior to case‐mix adjustment. In
Nils Gutacker, Yuanyuan Gu
wiley   +1 more source

A pre-illness reference reminder alters cross-sectional patient-reported outcome responses: evidence from EQ-5D-5L and EQ-HWB-9. [PDF]

Health Qual Life Outcomes
Ran X, Mu Q, Wang Q, Yang Z.
europepmc   +1 more source

Electronic Patient‐Reported Health‐Related Quality of Life Trajectories in ICU Survivors: A Multicentre Pilot Study‐Within‐a‐Trial Protocol

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 10, November 2026.
ABSTRACT Background Patient‐important outcomes beyond mortality, particularly health‐related quality of life (HRQoL), are frequently used in intensive care unit (ICU) trials. However, HRQoL assessment remains challenging due to methodological complexities, including poorly defined recovery trajectories, lack of consensus on measurement instruments ...
Elisa Zoe Battistelli, Benjamin Skov Kaas‐Hansen, Anders Granholm, Ronni Thermann Reitz Plovsing, Bodil Steen Rasmussen, Anders Perner, Maj‐Brit Nørregaard Kjær   +6 more
wiley   +1 more source

Choice and impact of EQ-5D-5L value set in cost-utility analyses alongside multinational trials: Insights from PREFERABLE-EFFECT and CONVINCE. [PDF]

PLoS One
Schouten AEM, Frederix GWJ, Stuiver MM, Fischer F, Hiensch AE, Cromm K, Canaud B, Strippoli GFM, May AM, van der Meulen MP, PREFERABLE-EFFECT Scientific Committee, and the CONVINCE Scientific Committee.   +11 more
europepmc   +1 more source

Static Otolith Signals Reflect Clinical Course in Acute Vestibular Neuritis

Clinical Otolaryngology, Volume 51, Issue 6, Page 861-866, November 2026.
ABSTRACT Objectives To investigate how static and dynamic utricular functions differentially correlate with dizziness symptoms and quality of life (QoL) recovery in patients with acute vestibular neuritis (VN). Design Prospective observational study with 1‐week and 1‐month follow‐up assessments. Setting Tertiary referral centre. Participants Twenty‐six
Seo‐Young Choi, Jae‐Hwan Choi, Hyun Sung Kim, Kwang‐Dong Choi   +3 more
wiley   +1 more source

A United Kingdom Value Set for the EQ-5D-5L

Value in Health
Rowen, D., Mukuria, C., Bray, N., Carlton, J., Longworth, L., Meads, D., Oluboyede, Y., O'Neill, C., Yang, Y.   +8 more
openaire   +2 more sources

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial

Arthritis &Rheumatology, Volume 78, Issue 10, Page 2089-2101, October 2026.
Objective Overweight or obesity is prevalent in 72% to 82% of individuals with psoriatic arthritis (PsA). We assessed the efficacy and safety of ixekizumab (IXE) concomitantly administered with tirzepatide (TZP) compared with IXE alone in adult participants with active PsA and overweight with at least one weight‐related comorbidity or obesity.
Joseph F. Merola, Philip Mease, Alan Kivitz, Naveed Sattar, Laura C. Coates, Daniel Aletaha, Cynthia E. Kartman, Peter Fischer, Luna Sun, Píndaro Martínez‐Osuna, Andris Kronbergs, Purvi Prajapati, Anabela Cardoso, Mark C. Genovese, Alexis Ogdie   +14 more
wiley   +1 more source

Efficacy and safety of cannabinoids in the treatment of spasticity in multiple sclerosis: A systematic review of randomized clinical trials

British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3288-3300, October 2026.
Aims This work aimed to evaluate the efficacy and safety of cannabinoids for the treatment of MS‐related spasticity. Methods Systematic searches were conducted in PubMed, EMBASE, and LILACS on 2 December 2025. Randomized controlled trials evaluating natural or synthetic cannabinoids for MS‐related spasticity were included.
Letícia Hamm‐Buiar, Daniela Gorski, Marcela Harumi Kagueiama, Astrid Wiens   +3 more
wiley   +1 more source